Oncolytic Virus Market Report

Global Oncolytic Virus Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：175
  • REPORT CODE：GMM860428
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Oncolytic Virus market report explains the definition, types, applications, major countries, and major players of the Oncolytic Virus market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer

    • Genelux

    • Takara Bio

    • Merck

    • Theravir

    • Shanghai Sunway Biotech

    • Cold Genesys

    • Neotropix

    • Roche

    • Latima

    • SillaJen

    • Otsuka Pharmaceutical Co

    By Type:

    • HSV-based Oncolytic Viruses

    • Adenoviruses-based Oncolytic Viruses

    • Vaccinia Virus-based Oncolytic Viruses

    • Vesicular Stomatitis Virus-based Oncolytic Viruses

    • Newcastle Disease Virus-based Oncolytic Viruses

    By End-User:

    • Pharmaceutical

    • Health Care

    • Commerical

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Oncolytic Virus Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Oncolytic Virus Outlook to 2028- Original Forecasts

    • 2.2 Oncolytic Virus Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Oncolytic Virus Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Oncolytic Virus Market- Recent Developments

    • 6.1 Oncolytic Virus Market News and Developments

    • 6.2 Oncolytic Virus Market Deals Landscape

    7 Oncolytic Virus Raw Materials and Cost Structure Analysis

    • 7.1 Oncolytic Virus Key Raw Materials

    • 7.2 Oncolytic Virus Price Trend of Key Raw Materials

    • 7.3 Oncolytic Virus Key Suppliers of Raw Materials

    • 7.4 Oncolytic Virus Market Concentration Rate of Raw Materials

    • 7.5 Oncolytic Virus Cost Structure Analysis

      • 7.5.1 Oncolytic Virus Raw Materials Analysis

      • 7.5.2 Oncolytic Virus Labor Cost Analysis

      • 7.5.3 Oncolytic Virus Manufacturing Expenses Analysis

    8 Global Oncolytic Virus Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Oncolytic Virus Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Oncolytic Virus Export by Region (Top 10 Countries) (2017-2028)

    9 Global Oncolytic Virus Market Outlook by Types and Applications to 2022

    • 9.1 Global Oncolytic Virus Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global HSV-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Adenoviruses-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Vaccinia Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Newcastle Disease Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oncolytic Virus Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceutical Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Health Care Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Commerical Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Oncolytic Virus Market Analysis and Outlook till 2022

    • 10.1 Global Oncolytic Virus Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Oncolytic Virus Consumption (2017-2022)

      • 10.2.2 Canada Oncolytic Virus Consumption (2017-2022)

      • 10.2.3 Mexico Oncolytic Virus Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Oncolytic Virus Consumption (2017-2022)

      • 10.3.2 UK Oncolytic Virus Consumption (2017-2022)

      • 10.3.3 Spain Oncolytic Virus Consumption (2017-2022)

      • 10.3.4 Belgium Oncolytic Virus Consumption (2017-2022)

      • 10.3.5 France Oncolytic Virus Consumption (2017-2022)

      • 10.3.6 Italy Oncolytic Virus Consumption (2017-2022)

      • 10.3.7 Denmark Oncolytic Virus Consumption (2017-2022)

      • 10.3.8 Finland Oncolytic Virus Consumption (2017-2022)

      • 10.3.9 Norway Oncolytic Virus Consumption (2017-2022)

      • 10.3.10 Sweden Oncolytic Virus Consumption (2017-2022)

      • 10.3.11 Poland Oncolytic Virus Consumption (2017-2022)

      • 10.3.12 Russia Oncolytic Virus Consumption (2017-2022)

      • 10.3.13 Turkey Oncolytic Virus Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Oncolytic Virus Consumption (2017-2022)

      • 10.4.2 Japan Oncolytic Virus Consumption (2017-2022)

      • 10.4.3 India Oncolytic Virus Consumption (2017-2022)

      • 10.4.4 South Korea Oncolytic Virus Consumption (2017-2022)

      • 10.4.5 Pakistan Oncolytic Virus Consumption (2017-2022)

      • 10.4.6 Bangladesh Oncolytic Virus Consumption (2017-2022)

      • 10.4.7 Indonesia Oncolytic Virus Consumption (2017-2022)

      • 10.4.8 Thailand Oncolytic Virus Consumption (2017-2022)

      • 10.4.9 Singapore Oncolytic Virus Consumption (2017-2022)

      • 10.4.10 Malaysia Oncolytic Virus Consumption (2017-2022)

      • 10.4.11 Philippines Oncolytic Virus Consumption (2017-2022)

      • 10.4.12 Vietnam Oncolytic Virus Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Oncolytic Virus Consumption (2017-2022)

      • 10.5.2 Colombia Oncolytic Virus Consumption (2017-2022)

      • 10.5.3 Chile Oncolytic Virus Consumption (2017-2022)

      • 10.5.4 Argentina Oncolytic Virus Consumption (2017-2022)

      • 10.5.5 Venezuela Oncolytic Virus Consumption (2017-2022)

      • 10.5.6 Peru Oncolytic Virus Consumption (2017-2022)

      • 10.5.7 Puerto Rico Oncolytic Virus Consumption (2017-2022)

      • 10.5.8 Ecuador Oncolytic Virus Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Oncolytic Virus Consumption (2017-2022)

      • 10.6.2 Kuwait Oncolytic Virus Consumption (2017-2022)

      • 10.6.3 Oman Oncolytic Virus Consumption (2017-2022)

      • 10.6.4 Qatar Oncolytic Virus Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Oncolytic Virus Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Oncolytic Virus Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Oncolytic Virus Consumption (2017-2022)

      • 10.7.2 South Africa Oncolytic Virus Consumption (2017-2022)

      • 10.7.3 Egypt Oncolytic Virus Consumption (2017-2022)

      • 10.7.4 Algeria Oncolytic Virus Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Oncolytic Virus Consumption (2017-2022)

      • 10.8.2 New Zealand Oncolytic Virus Consumption (2017-2022)

    11 Global Oncolytic Virus Competitive Analysis

    • 11.1 Pfizer

      • 11.1.1 Pfizer Company Details

      • 11.1.2 Pfizer Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Oncolytic Virus Main Business and Markets Served

      • 11.1.4 Pfizer Oncolytic Virus Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Genelux

      • 11.2.1 Genelux Company Details

      • 11.2.2 Genelux Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Genelux Oncolytic Virus Main Business and Markets Served

      • 11.2.4 Genelux Oncolytic Virus Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Takara Bio

      • 11.3.1 Takara Bio Company Details

      • 11.3.2 Takara Bio Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Takara Bio Oncolytic Virus Main Business and Markets Served

      • 11.3.4 Takara Bio Oncolytic Virus Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck

      • 11.4.1 Merck Company Details

      • 11.4.2 Merck Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck Oncolytic Virus Main Business and Markets Served

      • 11.4.4 Merck Oncolytic Virus Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Theravir

      • 11.5.1 Theravir Company Details

      • 11.5.2 Theravir Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Theravir Oncolytic Virus Main Business and Markets Served

      • 11.5.4 Theravir Oncolytic Virus Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Shanghai Sunway Biotech

      • 11.6.1 Shanghai Sunway Biotech Company Details

      • 11.6.2 Shanghai Sunway Biotech Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Shanghai Sunway Biotech Oncolytic Virus Main Business and Markets Served

      • 11.6.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Cold Genesys

      • 11.7.1 Cold Genesys Company Details

      • 11.7.2 Cold Genesys Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Cold Genesys Oncolytic Virus Main Business and Markets Served

      • 11.7.4 Cold Genesys Oncolytic Virus Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Neotropix

      • 11.8.1 Neotropix Company Details

      • 11.8.2 Neotropix Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Neotropix Oncolytic Virus Main Business and Markets Served

      • 11.8.4 Neotropix Oncolytic Virus Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Roche

      • 11.9.1 Roche Company Details

      • 11.9.2 Roche Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Roche Oncolytic Virus Main Business and Markets Served

      • 11.9.4 Roche Oncolytic Virus Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Latima

      • 11.10.1 Latima Company Details

      • 11.10.2 Latima Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Latima Oncolytic Virus Main Business and Markets Served

      • 11.10.4 Latima Oncolytic Virus Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 SillaJen

      • 11.11.1 SillaJen Company Details

      • 11.11.2 SillaJen Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 SillaJen Oncolytic Virus Main Business and Markets Served

      • 11.11.4 SillaJen Oncolytic Virus Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Otsuka Pharmaceutical Co

      • 11.12.1 Otsuka Pharmaceutical Co Company Details

      • 11.12.2 Otsuka Pharmaceutical Co Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Otsuka Pharmaceutical Co Oncolytic Virus Main Business and Markets Served

      • 11.12.4 Otsuka Pharmaceutical Co Oncolytic Virus Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Oncolytic Virus Market Outlook by Types and Applications to 2028

    • 12.1 Global Oncolytic Virus Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global HSV-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Adenoviruses-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Vaccinia Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Newcastle Disease Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Oncolytic Virus Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Health Care Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Commerical Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Oncolytic Virus Market Analysis and Outlook to 2028

    • 13.1 Global Oncolytic Virus Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.2.2 Canada Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Oncolytic Virus Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.2 UK Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.3 Spain Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.5 France Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.6 Italy Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.8 Finland Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.9 Norway Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.11 Poland Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.12 Russia Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Oncolytic Virus Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.2 Japan Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.3 India Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Oncolytic Virus Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.5.3 Chile Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.5.6 Peru Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Oncolytic Virus Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.6.3 Oman Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Oncolytic Virus Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Oncolytic Virus Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Oncolytic Virus Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Oncolytic Virus Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Oncolytic Virus

    • Figure of Oncolytic Virus Picture

    • Table Global Oncolytic Virus Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Oncolytic Virus Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global HSV-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

    • Figure Global Adenoviruses-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccinia Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

    • Figure Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

    • Figure Global Newcastle Disease Virus-based Oncolytic Viruses Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Global Health Care Consumption and Growth Rate (2017-2022)

    • Figure Global Commerical Consumption and Growth Rate (2017-2022)

    • Figure Global Oncolytic Virus Consumption by Country (2017-2022)

    • Table North America Oncolytic Virus Consumption by Country (2017-2022)

    • Figure United States Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Canada Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Mexico Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Table Europe Oncolytic Virus Consumption by Country (2017-2022)

    • Figure Germany Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure UK Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Spain Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Belgium Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure France Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Italy Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Denmark Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Finland Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Norway Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Sweden Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Poland Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Russia Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Turkey Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Table APAC Oncolytic Virus Consumption by Country (2017-2022)

    • Figure China Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Japan Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure India Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Thailand Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Singapore Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Philippines Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Table South America Oncolytic Virus Consumption by Country (2017-2022)

    • Figure Brazil Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Colombia Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Chile Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Argentina Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Peru Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Table GCC Oncolytic Virus Consumption by Country (2017-2022)

    • Figure Bahrain Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Oman Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Qatar Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Table Africa Oncolytic Virus Consumption by Country (2017-2022)

    • Figure Nigeria Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure South Africa Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Egypt Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure Algeria Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Table Oceania Oncolytic Virus Consumption by Country (2017-2022)

    • Figure Australia Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Oncolytic Virus Consumption and Growth Rate (2017-2022)

    • Table Pfizer Company Details

    • Table Pfizer Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Oncolytic Virus Main Business and Markets Served

    • Table Pfizer Oncolytic Virus Product Portfolio

    • Table Genelux Company Details

    • Table Genelux Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genelux Oncolytic Virus Main Business and Markets Served

    • Table Genelux Oncolytic Virus Product Portfolio

    • Table Takara Bio Company Details

    • Table Takara Bio Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takara Bio Oncolytic Virus Main Business and Markets Served

    • Table Takara Bio Oncolytic Virus Product Portfolio

    • Table Merck Company Details

    • Table Merck Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Oncolytic Virus Main Business and Markets Served

    • Table Merck Oncolytic Virus Product Portfolio

    • Table Theravir Company Details

    • Table Theravir Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Theravir Oncolytic Virus Main Business and Markets Served

    • Table Theravir Oncolytic Virus Product Portfolio

    • Table Shanghai Sunway Biotech Company Details

    • Table Shanghai Sunway Biotech Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Sunway Biotech Oncolytic Virus Main Business and Markets Served

    • Table Shanghai Sunway Biotech Oncolytic Virus Product Portfolio

    • Table Cold Genesys Company Details

    • Table Cold Genesys Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cold Genesys Oncolytic Virus Main Business and Markets Served

    • Table Cold Genesys Oncolytic Virus Product Portfolio

    • Table Neotropix Company Details

    • Table Neotropix Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neotropix Oncolytic Virus Main Business and Markets Served

    • Table Neotropix Oncolytic Virus Product Portfolio

    • Table Roche Company Details

    • Table Roche Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Oncolytic Virus Main Business and Markets Served

    • Table Roche Oncolytic Virus Product Portfolio

    • Table Latima Company Details

    • Table Latima Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Latima Oncolytic Virus Main Business and Markets Served

    • Table Latima Oncolytic Virus Product Portfolio

    • Table SillaJen Company Details

    • Table SillaJen Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table SillaJen Oncolytic Virus Main Business and Markets Served

    • Table SillaJen Oncolytic Virus Product Portfolio

    • Table Otsuka Pharmaceutical Co Company Details

    • Table Otsuka Pharmaceutical Co Oncolytic Virus Sales, Price, Value and Gross Profit (2017-2022)

    • Table Otsuka Pharmaceutical Co Oncolytic Virus Main Business and Markets Served

    • Table Otsuka Pharmaceutical Co Oncolytic Virus Product Portfolio

    • Figure Global HSV-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adenoviruses-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccinia Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vesicular Stomatitis Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Newcastle Disease Virus-based Oncolytic Viruses Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Health Care Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Commerical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Table North America Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Figure United States Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Figure Germany Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Figure China Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Figure Brazil Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Oncolytic Virus Consumption Forecast by Country (2022-2028)

    • Figure Australia Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Oncolytic Virus Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US